4//SEC Filing
Thompson Matthew 4
Accession 0001013606-20-000144
CIK 0001013606other
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 8:09 PM ET
Size
6.4 KB
Accession
0001013606-20-000144
Insider Transaction Report
Form 4
Thompson Matthew
Chief Medical Officer
Transactions
- Disposition to Issuer
Common Stock
2020-08-05+30,433→ 78,183 total - Disposition to Issuer
Common Stock
2020-08-05$0.07/sh−3,417$239→ 74,766 total
Footnotes (2)
- [F1]This award was originally reported on a Form 4 filed with the Securities and Exchange Commission on August 6, 2019. One-third of the shares subject to this restricted stock unit award vested pursuant to the terms of this award.
- [F2]Shares withheld on August 5, 2020 to satisfy statutory minimum tax withholding obligations related to shares vested on August 5, 2020.
Documents
Issuer
ENDOLOGIX INC /DE/
CIK 0001013606
Entity typeother
Related Parties
1- filerCIK 0001740988
Filing Metadata
- Form type
- 4
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 8:09 PM ET
- Size
- 6.4 KB